Literature DB >> 33961172

Reply to: "Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?"

Patrick J McCormick1,2, Melissa Assel3, Kimberly J Van Zee4,5, Andrew J Vickers6,7, Jonas A Nelson5,8, Monica Morrow4,5, Hanae K Tokita9, Brett A Simon9,10,11, Rebecca S Twersky9,10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33961172     DOI： 10.1245/s10434-021-10073-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  Postoperative Hematomas in the Era of Outpatient Mastectomy: Is Ketorolac Really to Blame?

Authors:  Sami M Abujbarah; Kristen Jogerst; Heidi E Kosiorek; Sarwat Ahmad; Patricia A Cronin; William Casey; Ryan Craner; Alanna Rebecca; Barbara A Pockaj
Journal:  Ann Surg Oncol       Date:  2022-07-18       Impact factor: 4.339

2.  ASO Author Reflections: Weighing the Risks and Benefits of Multimodal Analgesia Following Breast Surgery.

Authors:  Kristen M Jogerst; Sami M Abujbarah; Barbara Pockaj
Journal:  Ann Surg Oncol       Date:  2022-08-06       Impact factor: 4.339

3.  ASO Author Reflections: We No Longer Give Ketorolac During Mastectomy. Should You?

Authors:  Patrick J McCormick; Brett A Simon
Journal:  Ann Surg Oncol       Date:  2021-03-05       Impact factor: 4.339
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.